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Abstract
 
c-Cbl is an adaptor protein that negatively regulates signal transduction events involved in thymic-
positive selection. To further characterize the function of c-Cbl in T cell development, we analyzed
the effect of c-Cbl inactivation in mice deficient in the scaffolding molecule SLP-76. SLP-76–
deficient mice show a high frequency of neonatal lethality; and in surviving mice, T cell devel-
opment is blocked at the DN3 stage. Inactivation of 
 
c-cbl
 
 completely reversed the neonatal
lethality seen in SLP-76–deficient mice and partially reversed the T cell development arrest in
these mice. SLP-76
 
 
 
/
 
  
 
Cbl
 
 
 
/
 
  
 
mice exhibited marked expansion of polarized T helper type
(Th)1 and Th2 cell peripheral CD4
 
  
 
T cells, lymphoid infiltrates of parenchymal organs, and
premature death. This rescue of T cell development is T cell receptor dependent because it
does not occur in recombination activating gene 2
 
 
 
/
 
  
 
SLP-76
 
 
 
/
 
  
 
Cbl
 
 
 
/
 
  
 
triple knockout mice.
Analysis of the signal transduction properties of SLP-76
 
 
 
/
 
  
 
Cbl
 
 
 
/
 
  
 
T cells reveals a novel SLP-76–
and linker for activation of T cells–independent pathway of extracellular signal–regulated kinase
activation, which is normally down-regulated by c-Cbl.
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Introduction
 
T cell development and activation are regulated by signals
(1) resulting from the interaction between TCR and peptide/
MHCs on APCs. This signaling cascade is initiated by the
phosphorylation of TCR subunits by Lck, which in turn
creates binding sites for ZAP-70. Subsequently, the binding
of ZAP-70 to phosphorylated TCR leads to autophos-
phorylation and activation of ZAP-70 kinase activity (2–4).
Activated ZAP-70 phosphorylates downstream substrates,
such as SLP-76 and linker for activation of T cells (LAT),
which act as critical scaffolding molecules that bind and deliver
signals to molecules including phospholipase C
 
 
 
-1, Itk,
Vav, Grb2, extracellular signal–regulated kinases (ERKs),
and Gads (2–5). These biochemical events trigger the acti-
vation of transcription factors that participate in thymic devel-
opment and peripheral T cell responses. This model for sig-
nal transduction through a ZAP-70–LAT–SLP-76 pathway
is supported by studies using knockout mouse models in
which thymic development is blocked at the CD4
 
  
 
CD8
 
 
 
double negative (DN) stage in LAT- or SLP-76–deficient
mice (6–10).
TCR-mediated signaling is also modulated by negative
or inhibitory influences. Cbl family proteins have been
proposed to be critical factors in mediating this negative
regulation (11, 12). Three Cbl family members have been
identified as c-Cbl (Cbl), Cbl-b, and Cbl-3 (Cbl-c) in
mammalian cells. Cbl proteins consist of multiple func-
tional domains, including an NH
 
2
 
-terminal tyrosine kinase
binding domain, a ring finger, a proline-rich region, and a
COOH-terminal leucine-zipper/UBA domain (11). They
interact with multiple protein molecules to affect signaling
events via their protein–protein interaction domains. Re-
cently, the ring finger domains of Cbl proteins were shown
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to function as E3 ubiquitin ligases that down-regulate the
activities of signaling molecules associated with Cbl pro-
teins through protein ubiquitination/degradation (13, 14).
c-Cbl appears to have multiple and complicated influ-
ences on T cell development. Thymocytes from c-Cbl
knockout mice have enhanced cell surface expression of
TCR and CD3 in comparison to control mice (15, 16).
Studies of positive selection in a number of TCR transgenic
mouse models have further found that MHC class II–
restricted positive selection is markedly enhanced by c-Cbl
inactivation (15). In addition, it has been observed that
phosphorylation of ZAP-70, LAT, and SLP-76 is increased
in c-Cbl
 
 
 
/
 
  
 
mouse thymocytes (15–17). These observations
suggested that c-Cbl down-regulates a ZAP-70–dependent
TCR–CD3 signaling pathway, thus inhibiting T cell–posi-
tive selection during thymic development. However, a re-
cent report characterized a c-Cbl knock-in mouse with an
amino acid substitution in the c-Cbl protein that results in
loss of the ability to bind ZAP-70 (18). Unexpectedly, the
effect of this mutation differed from that of c-Cbl deletion
and did not result in any increase in phosphorylation of
LAT and SLP-76. CD3 expression was normal in double
positive (DP) thymocytes from mutant c-Cbl knock-in
mice, again in contrast to the enhanced CD3 expression in
c-Cbl knockout mice (18). These results suggest that c-Cbl
may also down-regulate TCR signaling through a mecha-
nism that is independent of a ZAP-70 pathway.
To further assess the possibility that c-Cbl proteins may in-
hibit T cell development through a pathway that is indepen-
dent of ZAP-70–LAT–SLP-76, we examined the effect of
c-Cbl inactivation in mice deficient in either SLP-76 or LAT.
Strikingly, c-Cbl inactivation completely reversed the neona-
tal lethality observed in SLP-76 knockout mice and partially
reversed their defect in thymic development. Moreover,
mice deficient in both c-Cbl and SLP-76 exhibited a marked
expansion of peripheral CD4
 
  
 
T cells as well as B cells and
macrophages, leading to splenomegaly and lymphadenopathy
as well as lymphoid infiltrates of multiple parenchymal or-
gans, and premature death in these mice. These peripheral
CD4
 
  
 
cells had decreased cell surface expression of CD3 and
TCR in contrast to the significant increase in CD3 and TCR
observed in single knockout c-Cbl
 
 
 
/
 
  
 
mice. The majority of
peripheral CD4
 
  
 
cells in SLP-76/Cbl-deficient mice were
polarized Th1 or Th2 cytokine-secreting cells. Interestingly,
however, SLP-76/Cbl-deficient CD4
 
  
 
cells were unrespon-
sive to TCR stimulation in vitro, but exhibited a constitutive
phosphorylation of ERKs ex vivo. Thus, c-Cbl inactivation
partially bypasses the defects seen in SLP-76–deficient mice
and results in dysregulated and SLP-76–independent expan-
sion of Th1/Th2 polarized CD4
 
  
 
T cells. LAT
 
 
 
/
 
  
 
Cbl
 
 
 
/
 
 
 
mice were found to express a phenotype similar to that of
SLP-76
 
 
 
/
 
  
 
Cbl
 
 
 
/
 
  
 
mice. In contrast, SLP-76
 
 
 
/
 
  
 
Cbl
 
 
 
/
 
 
 
RAG-2
 
 
 
/
 
  
 
triple knockout mice failed to show rescue of T
cell development. These findings indicate that inactivation of
c-Cbl results in partial reversal of the defects in T cell devel-
opment seen in SLP-76
 
 
 
/
 
  
 
mice through a LAT- and SLP-
76–independent but TCR-dependent signaling pathway.
 
Materials and Methods
 
Mice.
 
C-Cbl knockout (Cbl
 
 
 
/
 
 
 
), LAT knockout (LAT
 
 
 
/
 
 
 
),
RAG-2 knockout (RAG-2
 
 
 
/
 
 
 
), and SLP-76 knockout (SLP-76
 
 
 
/
 
 
 
)
were mice generated as described previously (8, 10, 15). The
c-Cbl knockout line was maintained by breeding homozygous
knockout mice (c-Cbl
 
 
 
/
 
 
 
), and SLP-76 knockouts were main-
tained as heterozygous mice (SLP-76
 
 
 
/
 
 
 
) that were intercrossed to
generate SLP-76
 
 
 
/
 
 
 
, SLP-76
 
 
 
/
 
 
 
, and SLP-76
 
 
 
/
 
  
 
offspring. The
LAT knockout line was maintained by breeding homozygous
knockout mice (LAT
 
 
 
/
 
 
 
). All animals were housed at Bioqual.
 
Abs.
 
Anti–mouse CD3 (2C11), anti-CD28 (4F10), anti–
ZAP-70, anti-CD4 PE, anti–IL-4 PE, anti–IL-2 PE, anti–IFN-
 
 
 
PE, anti-CD8 FITC, anti-CD25 biotin, anti–human CD3 (leu-4)
biotin, anti-CD62L biotin, and anti–TCR-
 
  
 
(H57) biotin mAbs
were purchased from BD Biosciences. Anti–phospho-tyrosine
(4G10) mAb was purchased from Upstate Biotechnology. Anti-
Lck, anti-ERK, and polyclonal Ab specific for serine- and tyro-
sine-phosphorylated ERK were purchased from Cell Signaling.
 
T Cell Proliferation and IL-2 Assays.
 
T cells or CD4
 
  
 
T cells
were purified from spleens or lymph nodes of 6–8-wk-old mice us-
ing T cell or CD4 cell separation columns (Accurate), respectively.
For T cell proliferation assays, 100 
 
 
 
l purified CD4
 
  
 
cells (10
 
6
 
/ml)
were cultured in a 96-well plate precoated with 1 
 
 
 
g/ml CD3 Ab
at 37
 
 
 
C for 48 h. 1 
 
 
 
l/well [
 
3
 
H]thymidine was added and [
 
3
 
H]thy-
midine incorporation was measured after an additional culture of
16 h at 37
 
 
 
C. For IL-2 assay, 10
 
5 
 
cells (100 
 
 
 
l) were cultured in a
96-well plate with 10 
 
 
 
g/ml anti-CD3 Ab in the presence or ab-
sence of 1 
 
 
 
g/ml soluble anti-CD28 Ab (19). Supernatant was col-
lected after 48 h of culture at 37
 
 
 
C and secreted IL-2 in the super-
natant was detected using an ELISA kit (BD Biosciences).
 
Intracellular Cytokine Staining.
 
Lymphoid cells were stimu-
lated with 200 ng/ml PMA and 300 ng/ml ionomycin for 4 h. 2
 
 
 
m monensin was added and cells were cultured for an additional
2 h (20). Cells were harvested and fixed with 4% paraformalde-
hyde for 20 min at room temperature, and fixed cells were
stained with Abs as indicated and analyzed by flow cytometry us-
ing a FACScan™ (Becton Dickinson; reference 20).
 
Measurement of Intracellular Calcium Concentration.
 
For intra-
cellular calcium determination, 2 
 
  
 
10
 
6 
 
spleen cells were sus-
pended in 1 ml of HBSS buffer containing 0.5% BSA and 1.8 mM
Indo 1-AM (Molecular Probes) and incubated at 37
 
 
 
C for 30 min.
The indo-1–loaded cells were then washed twice with HBSS
buffer and incubated with biotin-conjugated anti-CD3 and anti-
CD4 mAbs, followed by staining with anti-CD4 FITC Ab to al-
low detection and gating of CD4
 
  
 
cells. The stained cells were
warmed to 37
 
 
 
C and analyzed on a FACStar™ (Becton Dickin-
son) for responses to 1 
 
 
 
g streptavidin or 2 
 
 
 
g ionomycin. For
indo-1 fluorescence excitation, the Inova-305 laser was tuned to
200 mW power UV excitation. The emitted indo-1 fluorescence
at 405 and 510 nm was collected (21). The 405:510 nm fluores-
cence ratio as a measurement of Ca
 
2
 
  
 
was calculated and kinetics
were plotted with the FlowJo program (TreeStar, Inc.).
 
Western Blot Analysis
 
T cells were enriched from spleen and
lymph node by negative selection with anti-mIg Ab. Enriched T
cells were incubated with 10 
 
 
 
g/ml biotin-conjugated anti-CD3
and anti-CD4 Abs for 30 min, and then stimulated with 20 
 
 
 
g/
ml streptavidin for the indicated time (19). The stimulated cells
were lysed in buffer containing 50 
 
 
 
m Tris, pH 7.4, 150 
 
 
 
m
NaCl, 1 mM Na
 
2
 
VO
 
4
 
, 1% NP-40, and protease inhibitor cock-
tail. Protein lysates were used for biochemical analysis.
 
Online Supplemental Materials.
 
Results of experiments, which
complement the data presented in this study, are shown in Figs. 
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S1–S3. In Fig. S1, the expression of CD4 on peripheral CD4
 
  
 
T
cells of WT, LAT
 
 
 
/
 
  
 
Cbl
 
 
 
/
 
 
 
, and SLP-76
 
 
 
/
 
  
 
Cbl
 
 
 
/
 
  
 
mice is ana-
lyzed by flow cytometry. In Fig. S2, lymph nodes and spleens
from WT and SLP-76
 
 
 
/
 
  
 
Cbl
 
 
 
/
 
  
 
mice at the age of 16 wk were
isolated and photographed. In Fig. S3, DN cells were purified
from thymocytes by depleting CD4
 
  
 
and CD8
 
  
 
cells with mouse
CD4 and CD8 MicroBeads (Miltenyi Biotec). 3 
 
  
 
10
 
6 
 
DN cells
from WT, c-Cbl / , SLP-76 / , and SLP-76 /  Cbl /  mice
were lysed and immunoblotted with anti–Zap-70 and anti-actin
Abs as described above. Figs. S1–S3 are available at http://
www.jem.org/cgi/content/full/jem.20040262/DC1.
Results
Generation of SLP-76 /  Cbl /  Double Knockout Mice.
SLP-76 /  Cbl /  double knockout mice were generated by
intercrossing SLP-76 /  Cbl /  mice. All mice were geno-
typed at 4 wk of age. As expected from previous reports (6,
9), by the time of weaning there was a selective loss of SLP-
76 /  progeny (Table I) attributable to platelet dysfunction
(8) and a more recently described failure of normal vascular
development (22). Surprisingly, however, concomitant loss
of c-Cbl and SLP-76 rescues the perinatal lethality, as the ob-
served proportion of SLP-76 /  Cbl /  mice was equivalent
to that expected by Mendelian segregation (Table I). The
mechanism by which c-Cbl mutation reverses the survival
defect of SLP-76 /  mice is currently under investigation.
Table I. The Perinatal Lethal Defect of SLP-76 Knockout Mice Is 
Rescued by c-Cbl Inactivation
SLP-76 genotypes
Total offspring            
SLP-76    Exp. 32 64 32
  127
SLP-76    Obs. 41 78 8
SLP-76    Cbl    Exp. 19 39 19
  78
SLP-76    Cbl    Obs. 19 38 21
Exp., expected; Obs., observed.
Figure 1. Inactivation of c-Cbl partially reverses the defect of thymic development of SLP-76    or LAT    mice but does not reverse the defect of
thymic development of RAG-2    SLP-76    mice. (a) CD4/CD8 profiles and thymic cellularity of WT, Cbl /  LAT / , SLP-76 / , SLP-76 /  Cbl / ,
and LAT / Cbl /  mice at 6 wk of age. (b) CD4/CD8/NK1.1/Mac-1/Gr1/CD3/B220  thymocytes from the indicated mice were analyzed for surface
expression of CD44 and CD25 by flow cytometry. (c) CD4 SP cells and CD4/CD8 DP cells from the indicated mouse thymi were analyzed for the ex-
pression of CD3 and TCR-  (H57). The results presented are representative of more than five experiments. (d) CD4/CD8 profiles in WT, RAG-2 / ,
and RAG-2 /  SLP-76 /  Cbl /  mouse thymi and spleens. The results presented are representative of three experiments.Regulation of T Cell Development and Activation by c-Cbl 28
c-Cbl Inactivation Allows Development of DP and CD4 Sin-
gle Positive (SP) Thymocytes in SLP-76    or LAT    Mice.
As previously reported, thymic development in SLP-76 / 
mice is arrested at the CD4  CD8  (DN) stage with total
number of thymocytes severely reduced in comparison to
WT mice (8, 9). In SLP-76 /  Cbl /  double knockout
mice, total cellularity of thymus was not different from that
of SLP-76 /  mice. However, in contrast to SLP-76 / 
mice, SLP-76 /  Cbl /  mice generated significant propor-
tions of CD4  CD8  (DP) and CD4  CD8  (SP) cells, al-
though in numbers substantially lower than those observed
in WT or Cbl /  thymi (Fig. 1 a). The proportion of CD4 
and DP cells varied in thymi of individual mice, with 6-wk-
old SLP-76 /  Cbl /  mice expressing an average of 10%
DP cells and 5% CD4  cells compared to the absence of de-
tectable DP and CD4 SP cells in SLP-76 /  single knock-
outs. The majority of DN thymocytes were CD25  CD44 
(DN3) in SLP-76 /  Cbl /  mice, as in SLP-76 /  mice
(Fig. 1 b). Cell surface expression of CD3 or TCR-  was
significantly decreased on SLP-76 /  Cbl /  thymic CD4
SP cells relative to expression on WT thymic CD4 SP cells
and to the increased expression observed in c-Cbl /  mice.
In contrast, SLP-76 /  Cbl /  DP cells expressed CD3 and
TCR-  at markedly enhanced levels that were similar to
those observed in c-Cbl /  DP cells (Fig. 1 c). Expression
of CD5 and CD69 was increased on both DP and CD4 SP
SLP-76 /  Cbl /  thymocytes relative to WT or c-Cbl sin-
gle knockout mice (unpublished data).
The ability of c-Cbl inactivation to partially rescue T cell
development in SLP-76–deficient mice suggested the exist-
ence of a developmental pathway distinct from that involv-
ing the conical TCR→ZAP70→LAT→SLP-76 pathway.
To further test this possibility, the effect of c-Cbl inactiva-
tion on T cell development was studied in LAT-deficient
mice. T cell development in LAT /  mice is also arrested
at the DN stage (10) with absence of DP and SP thy-
mocytes, similar to the SLP-76 /  phenotype. c-Cbl inac-
tivation induced partial rescue of thymic development in
LAT /  Cbl /  mice, similar to the effect observed in SLP-
76 /  Cbl /  mice. Fig. 1 a shows that  24% DP and 7%
CD4 SP cells were detected in LAT /  Cbl /  thymi but
not in LAT /  thymi. As seen in SLP-76 /  Cbl /  mice,
c-Cbl inactivation only partially reversed the defects of
thymic development in LAT /  mice. The cellularity of
LAT /  Cbl /  thymi was  1/20 that of WT mice, and T
cell development of LAT /  Cbl /  mice showed a block
at DN3 (Fig. 1 b), similar to that in LAT /  or SLP-76 / 
mice. As was seen in SLP-76/c-Cbl double deficient mice,
decreased expression of CD3 and TCR-  was observed in
LAT /  Cbl /  CD4 SP cells, whereas expression of CD3
and TCR-   was enhanced in LAT /  Cbl /  DP cells
(unpublished data).
Figure 2. There is a marked
expansion of peripheral CD4 T
cells in SLP-76    Cbl    mice.
(a) CD4/CD8 profiles of spleens
of WT, Cbl / , LAT / , SLP-
76 / , SLP-76 /  Cbl / , and
LAT /  Cbl /  mice at 6 wk of
age. (b) Gated peripheral CD4 
cells of WT, Cbl / , and SLP-
76 /  Cbl /  mice were analyzed
for the expression of CD3,
TCR-   (H57), and CD28. (c)
Gated peripheral CD4  cells of
WT and SLP-76 /  Cbl /  mice
were analyzed for the expression
of CD25 and CD62L. (d) Per-
centage of CD4  cells of WT
and SLP-76 /  Cbl /   PBLs was
determined at the indicated ages.
(e) Hematoxylin and eosin stain-
ing of sections from the lungs
and livers of WT and SLP-76 / 
Cbl /  mice at  24 wk of age.
Magnification, 20. The flow cyto-
metric  results shown are re-
presentative of more than five
experiments.Chiang et al. 29
Inactivation of c-Cbl Does Not Rescue the T Cell Defects in
RAG-2 /  SLP-76 /  Mice. c-Cbl inactivation rescued
significant T cell development in the absence of SLP-76 or
LAT, two scaffolding molecules that appear to be other-
wise critical for TCR-mediated signal transduction. There-
fore, it was of interest to determine whether T cell devel-
opment in SLP-76 /   Cbl /   mice is in fact TCR
independent. To test this possibility, RAG-2 /  SLP-76 / 
Cbl /  triple knockout mice were bred in which expres-
sion of rearranged TCR genes cannot occur. No DP or SP
T cells were detected in RAG-2 /   mouse thymi or
spleens, as expected. RAG-2 /  SLP-76 /  Cbl /  triple
knockout mice similarly had no DP or SP T cells in either
the thymus or spleen (Fig. 1 d). This finding indicates that
c-Cbl inactivation permits T cell development through an
SLP-76– and LAT-independent, but nevertheless TCR-
dependent, mechanism.
Massive Splenomegaly and Lymphadenopathy Develop in
SLP-76 /  Cbl /  and LAT /  Cbl /  Mice. In contrast
to SLP-76 /  and LAT /  mice that do not have periph-
eral T cells, SLP-76 /  Cbl /  and LAT /  Cbl /  mice
had substantial numbers of peripheral CD4  T cells (Fig. 2
a). Remarkably, the total number of CD4  T cells in the
spleen and lymph nodes of 6-wk-old SLP-76 /  Cbl /  or
LAT /  Cbl /  mice was in fact markedly elevated above
numbers in WT or c-Cbl /  mice. In distinction to the
observed increase in numbers of CD4  T cells, there were
few if any peripheral CD8  T cells in SLP-76 /  Cbl / 
mice. SLP-76 /  Cbl /  mice had  10 times the number
of splenic and lymph node CD4  cells in comparison to ei-
ther WT or c-Cbl /  mice at the age of 24 wk.
Phenotypic analysis also demonstrated that the periph-
eral CD4  population in SLP-76 /  Cbl /  mice differs
from that in WT controls or c-Cbl /  mice. In compari-
son to WT or c-Cbl /  mice, CD3 and TCR-  expres-
sion was markedly reduced and CD4 was modestly but
consistently reduced in SLP-76 /   Cbl /   peripheral
CD4  cells (Fig. 2, a and b, and Fig. S1, available at http:
//www.jem.org/cgi/content/full/jem.20040262/DC1).
CD28 expression on SLP-76 /  Cbl /  CD4  cells was
equivalent to that on WT cells (Fig. 2, a and b). The
CD25  CD4  subpopulation of CD4  T cells that is ob-
served in WT mice, and commonly associated with sup-
pressor or regulatory function, is largely absent in SLP-
76 /  Cbl /  spleen and lymph nodes. SLP-76 /  Cbl / 
CD4  cells also have dramatically decreased expression of
CD62L compared to WT CD4  cells (Fig. 2 c), suggesting
that this is a population of previously activated cells. The
expansion of SLP-76 /  Cbl /  CD4  cells was polyclonal
as analyzed by TCR V  usage (unpublished data). The
proportion of Mac-1  cells in the SLP-76 /  Cbl /  mice
( 20%) was substantially greater than that in controls
( 5%), as were total numbers of Mac-1  cells (Table II).
Total B cell numbers were also increased in the spleens
and lymph nodes of SLP-76 /  Cbl /  mice compared to
control mice, although the proportion of B cells was not
dramatically increased (Table II).
SLP-76 /  Cbl /  mice developed progressive spleno-
megaly and lymphadenopathy with age and died at  6 mo.
Older (4–6-mo-old) SLP-76 /  Cbl /  mice had approxi-
mately 8–12 times the number of splenic CD4  cells ob-
served in age-matched control WT or c-Cbl /  mice and
three to four times the number found in young SLP-76 / 
Cbl /  mice (Table II and Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20040262/DC1). Old
SLP-76 /  Cbl /  mice also had more B cells and macro-
phages in the spleen and lymph nodes than in control mice.
The increase in peripheral CD4  T cells was also reflected
in an increasing CD4  cell percentage in PBL with age of
SLP-76 /  Cbl /  mice (Fig. 2 d). To further analyze the
state of other organ systems and potential contributors to
the early death observed in SLP-76 /  Cbl /  mice, histo-
logical analysis was performed. Extensive lymphocyte in-
filtration was observed in the lungs and livers of SLP-
76 /  Cbl /  mice. Lymphocytes were observed as clusters
around pulmonary vessels, bronchioles, and hepatic paren-
chyma in SLP-76 /  Cbl /  mice but not in normal mice
(Fig. 2 a). Occasionally, clusters of multinucleate giant cells
were detected. Increased numbers of macrophages were
also observed in the lungs of SLP-76 /  Cbl /  mice. Sim-
ilar findings were observed in LAT /  Cbl /  mice (un-
published data).
SLP-76 /  Cbl /  Peripheral CD4  Cells Are Polarized to
Th1 and Th2 Cell Cytokine Secretion. In normal mice, the
majority of peripheral T cells are naive CD62Lhi cells that
have not encountered antigen and are not differentiated
into specialized cells capable of secreting Th1 and Th2 cell
cytokines. It was of interest to determine whether the pe-
ripheral CD4  T cells found in SLP-76 /  Cbl /  mice,
the majority of which express a CD62Llo memory cell phe-
notype, were functionally differentiated. More than 50%
of SLP6 /  Cbl /  CD4 cells were IL-4–producing cells
when acutely stimulated with PMA and ionomycin,
whereas IL-4–producing CD4  cells were essentially unde-
tectable in WT or c-Cbl /  mice (Fig. 3 a). The propor-
tions of IL-2– and IFN- –producing cells were also in-
creased in SLP-76 /  Cbl /  CD4  cells. Multiparameter
staining demonstrated that IL-4– and IFN- –producing
cells represented mutually exclusive populations (Fig. 3 b).
Table II. The Distribution of Splenocytes Subpopulations
Cell number ( 106)
Total CD4 CD8 B cell Mac-1  cells
WT (6 wk) 138 11 6.9 11 5.8
WT (24 wk) 120 26.5 15.8 69 6.4
SLP-76    Cbl    (6 wk) 430 25.8 1 317 82
SLP-76    Cbl    (24 wk) 820 295 4.3 335 180
The results presented are for individual mice and are representative of
three to five mice per group.Regulation of T Cell Development and Activation by c-Cbl 30
The peripheral CD4  T cells that are expanded in SLP-
76 /  Cbl /  mice thus appear to represent differentiated
and polarized Th2 (IL-4) and Th1 (IFN- ) cell popula-
tions. Consistent with the observed expansion of Th2 cyto-
kine-secreting cells, a dramatic increase in Th2 cell–depen-
dent IgE and IgG1 was detected in the serum of SLP-76 / 
Cbl /  mice with total IgE increased  105 times above
levels in WT mice, and IgG1 102–103 times higher than
controls (Fig. 3 c). Despite these elevated levels of total Ig,
immunization with TNP-KLH failed to induce antigen-
specific Ig responses (unpublished data).
SLP-76 /   Cbl /   CD4   T Cells Are Unresponsive to
TCR Stimulation. To test the function of SLP-76 / 
Cbl /  CD4  cells in vitro, enriched peripheral T cells
were treated with titrated concentration of anti-CD3 Ab in
the presence or absence of anti-CD28 Ab. Although WT
CD4  cells proliferated and produced IL-2 in response to
TCR stimulation in vitro, SLP-76 /  Cbl /  CD4  cells
did not respond detectably to the same stimuli (Fig. 4). To
measure early and proximal signaling events in response to
TCR stimulation, intracellular Ca2  flux was analyzed. WT
CD4  cells generated Ca2  responses to CD3/CD4 cross-
linking, and c-Cbl /  CD4  cells exhibited detectable but
reduced Ca2  responses, a finding not previously reported.
In contrast, there was no detectable Ca2  response in SLP-
76 /  Cbl /  CD4  cells (Fig. 5).
As noted above, SLP-76 /  Cbl /  CD4  T cells failed
to respond to TCR stimulation in vitro as measured by
proliferation, IL-2 production, or Ca2  flux. Therefore, ad-
ditional parameters were measured in further efforts to de-
tect biochemical responses to TCR stimulation. Enriched
CD4  cells were stimulated with anti-CD3/CD4 Abs and
cell lysates were analyzed for total tyrosine phosphoryla-
tion. Tyrosine phosphorylation of a 110-kD protein, prob-
ably c-Cbl, was observed in WT but not c-Cbl /  or SLP-
76 /  Cbl /  CD4  cells in response to TCR stimulation.
Additional tyrosine phosphorylated proteins, including 37-
(probably LAT) and 23-kD (probably TCR-  chain) spe-
cies, were detected in WT and c-Cbl /  but not SLP-76 / 
Cbl /  CD4  cells. In fact, there was no detectable tyrosine
phosphorylation induced in SLP-76 /  Cbl /  CD4  cells
in response to TCR stimulation (Fig. 6 a).
ERK Is Constitutively Phosphorylated in SLP-76 /  Cbl / 
CD4  T Cells. Several bands representing proteins 65–80
kD were constitutively tyrosine phosphorylated in the ab-
sence of in vitro stimulation in WT and c-Cbl /  T cells,
but not in SLP-76 /  Cbl /  T cells. In contrast, one con-
stitutively phosphorylated 45-kD protein showed the recip-
rocal pattern and was detected in SLP-76 /  Cbl /  CD4 
cells but not in WT or c-Cbl /  CD4  cells (Fig. 6 b).
To identify specific tyrosine phosphorylated proteins,
ERK was first analyzed as a candidate for the 45-kD phos-
phoprotein detected constitutively in SLP-76 /  Cbl /  T
cells. Cell lysates were fractionated by gel electrophoresis
and immunoblotted with Abs specific for total or phos-
phorylated protein. ERK was expressed at similar total pro-
tein levels in WT, c-Cbl / , and SLP-76 /  Cbl /  T
cells. ERK phosphorylation was low to undetectable in un-
Figure 3. Peripheral CD4  T
cells in SLP-76    Cbl    mice are
polarized to IL-4 or IFN-  pro-
duction. (a) IL-2, IL-4, and IFN- 
intracellular staining for PMA/
ionomycin-stimulated CD4  cells
from indicated mice. (b) IFN- 
and IL-4 double intracellular
staining for PMA/ionomycin-
stimulated CD4  cells from indi-
cated mice. (c) Ig production in
WT and SLP-76 /  Cbl /  mice.
The results are representative of
three experiments.
Figure 4. T cell proliferation and IL-2 production in response to TCR
stimulation are deficient in peripheral CD4  cells from SLP-76    Cbl   
mice. (a) T cell proliferation assay: 105 cells were plated in 96-well plates
precoated with anti-CD3 Abs. (b) IL-2 induction: 106 CD4 cells were
plated in 24-well plates coated with 10  g/ml anti-CD3 Ab in the pres-
ence of 1  g/ml anti-CD28 Ab. B.D., below detection. The results are
representative of three experiments.Chiang et al. 31
stimulated WT or c-Cbl /  T cells, and increased in re-
sponse to TCR stimulation. In contrast, both Erk1 and
Erk2 were found to be constitutively phosphorylated in
SLP-76 /  Cbl /  CD4  T cells, and ERK phosphoryla-
tion was not increased in response to TCR stimulation in
these cells (Fig. 6 b).
ZAP-70 and Lck Are Expressed at Greatly Reduced Levels
in SLP-76 /  Cbl /  CD4  Cells. Tyrosine phosphoryla-
tion of ZAP-70 is a critical event in normal T cell develop-
ment and activation, and appears to be upstream of LAT
and SLP-76 in TCR-initiated signal transduction pathways.
Because no tyrosine phosphorylation of ZAP-70 was de-
tected in SLP-76 /  Cbl /  T cells, levels of total ZAP-70
expression were measured in SLP-76 /  Cbl /  and con-
trol CD4  cells by immunoblotting with two different
anti–ZAP-70 Abs. Surprisingly, total ZAP-70 protein in
SLP-76 /  Cbl /  CD4  cells was only one tenth the level
detected in WT or c-Cbl / –deficient CD4  T cells. Lck
protein expression was also reduced  10-fold in SLP-76 / 
Cbl /  CD4  cells (Fig. 6 c). In contrast, there was no
difference in expression of ERK1 or ERK2 in the double
knockout or control CD4  cells (Fig. 6 c). RT-PCR anal-
ysis showed that equivalent steady state levels of both ZAP-
70 and Lck mRNA were expressed in WT, c-Cbl / , and
SLP-76 /  Cbl /  CD4 T cells, indicating that the reduced
expression of ZAP-70 and Lck protein in the double
knockout CD4  cells occurs at a translational or posttrans-
lational level (unpublished data).
To determine whether expression of ZAP-70 protein
was also altered in developing SLP-76 /   Cbl /   thy-
mocytes, lysates from predominantly DN SLP-76 /  Cbl / 
thymocytes were compared with purified WT DN thy-
mocytes by immunoblotting. In contrast to the greatly re-
duced levels of ZAP-70 observed in peripheral CD4  cells,
ZAP-70 expression was not comparably decreased in SLP-
76 /  Cbl /  thymic lysates (Fig. S2). Therefore, reduction
in ZAP-70 protein is most marked in peripheral CD4  cells
Figure 5. Ca2  influx in response to anti-
CD3/CD4 stimulation is deficient in peripheral
CD4   cells from SLP-76     Cbl     mice.
CD4  T cells were isolated and assayed for
Ca2  response as described in Materials and
Methods. Arrows indicate the time at which
streptavidin or ionomycin was added. The results
presented are representative of three experiments.
Figure 6. (a) SLP-76    Cbl    T cells fail to induce protein tyrosine
phosphorylation in response to TCR engagement. Enriched T cells (75–
85% T cells) from the indicated mouse lymph nodes and spleens were
stimulated with anti-CD3/CD4 Abs or anti-CD3/CD28 Abs. The pro-
tein lysates were blotted with 4G10 anti-phosphotyrosine Ab. (b) ERKs
of SLP-76    Cbl    T cells are constitutively phosphorylated. The blots
from (a) were stripped and blotted with anti-ERK or anti-phospho-
ERKs Abs. (c) The expression of ZAP-70 and Lck is reduced in SLP-
76    Cbl    CD4  cells. Purified CD4 cells from the indicated mouse
lymph nodes and spleens were blotted with anti–ZAP-70, anti-Lck, anti-
ERKs, and anti-actin Abs. The results presented are representative of
three experiments.Regulation of T Cell Development and Activation by c-Cbl 32
and appears to reflect later events in development or pe-
ripheral differentiation.
Discussion
In this study, we have analyzed the effect of c-Cbl inac-
tivation on the phenotype observed in SLP-76 knockout
and LAT knockout mice. The inactivation of c-Cbl res-
cued completely the perinatal survival defect in SLP-76 / 
mice and partially overcame the deficiency of T cell devel-
opment in both SLP-76 /  and LAT /  mice. SLP-76 / 
Cbl /  double knockout or LAT /  Cbl /  double knock-
out mice developed progressive splenomegaly and lym-
phadenopathy, and died by 6 mo of age with lymphoid
infiltration of parenchymal organs. Hyperplasia was domi-
nated by peripheral CD4  T cells that were polarized to
differentiated Th1 or Th2 cytokine-producing cells. In
contrast, RAG-2 /   SLP-76 /   Cbl /   triple knockout
mice did not generate DP or SP T cells. In vitro TCR
stimulation of SLP-76 /  Cbl /  CD4  cells failed to in-
duce T cell proliferation, IL-2 production, Ca2  influx, or
protein tyrosine phosphorylation.
The majority of SLP-76 knockout mice die in the first
week after birth (6, 9). This early lethality is completely res-
cued by c-Cbl inactivation with SLP-76 /  Cbl /  double
knockout mice surviving through early adulthood, but subse-
quently dying by  6 mo of age. The precise mechanism of
the early mortality of SLP-76 /  mice is not yet completely
understood, however, it is likely a consequence of a vascular
development defect and platelet signaling abnormalities. The
mechanism by which c-Cbl inactivation rescues early lethality
has not yet been established, but preliminary results suggest
that partial reversal of both platelet and vascular abnormalities
occurs in SLP-76 /  Cbl /  mice (unpublished data).
The finding of splenomegaly and lymphadenopathy with
massive expansion of CD4  cells was unexpected. It was
notable that these mice are deficient in the CD4  CD25 
subpopulation that in many settings functions as a regulatory
population capable of suppressing T cell proliferation and
IL-2 production (23, 24). The loss of T cell suppressor func-
tion could contribute to dysregulated proliferation in SLP-
76 /  Cbl /  or LAT /  Cbl /  CD4  cells, a possibility
that is currently being investigated. The observation that
most SLP-76 /  Cbl /  CD4  cells are differentiated into
Th1 and Th2 cells suggests that these T cells have responded
in vivo to unknown stimuli, despite their in vitro unrespon-
siveness to TCR stimulation. The decreased TCR density
observed on the surface of SLP-76 /  Cbl /  CD4  cells is
in fact consistent with their in vivo activation, and the fail-
ure to rescue T cell development in RAG-2 /  SLP-76 / 
Cbl /  mice further reinforces the possibility that the phe-
notype of peripheral T cell expansion reflects chronic
TCR-dependent stimulation. The relationship between pe-
ripheral CD4  T cells and the small number of thymocytes
observed in SLP-76 /  Cbl /  thymi is unclear, and it is
possible that the thymic CD4 SP cells are at least in part de-
rived from recirculating peripheral CD4  T cells.
SLP-76 is a central adaptor protein for T cell develop-
ment. T cell development of SLP-76 /  mice is arrested at
the DN3 stage (8, 9) presumably because in the absence of
SLP-76, pre-TCR signals cannot be transmitted to down-
stream signaling molecules such as Vav, Grb2, Gads, and
PLC- 1, all of which interact with SLP-76 (2–5, 25).
c-Cbl mutation partially overcame the defects in T cell de-
velopment of SLP-76  /  mice. In studies of the TCR sig-
naling capacity of SLP-76 /  Cbl /  CD4  T cells, these
cells failed to produce detectable tyrosine phosphorylation
in response to in vitro TCR stimulation. However, consti-
tutive tyrosine phosphorylation of ERKs was observed in
SLP-76 /  Cbl /  CD4  cells, which was not seen in ei-
ther WT or c-Cbl /  T cells. c-Cbl binds to multiple mol-
ecules involved in signal transduction, and could in princi-
ple negatively regulate the function of these molecules by
competitive binding or by inducing ubiquitin-dependent
degradation through its E3 ligase activity. Based on the
findings reported here, we hypothesize that SLP-76 / 
Cbl /  T cells use an alternative ERK signaling pathway to
partially reverse the defects of T cell development in SLP-
76 /  mice. Ca2  signaling as well as ERK signaling are
essential for normal T cell development. In WT T cells,
c-Cbl constitutively binds to critical signal molecules such as
Grb2 (26, 27), serving to maintain T cells in an inactivated
state in the absence of TCR stimulation. SLP-76 /  mice
cannot transmit either Ca2  or ERK signals from the TCR
or pre-TCR, resulting in an essentially complete block of
T cell development at the DN3 stage. In contrast, SLP-
76 /  Cbl /  cells constitutively activate ERK, possibly
through a Grb2–SOS pathway resulting from the release of
Grb2 molecules in the absence of c-Cbl. The events that
might contribute to this ERK activation are not fully de-
fined, but appear to require TCR expression, despite the
fact that SLP-76 /  Cbl /  T cells did not produce detect-
able Ca2  or ERK signals in response to in vitro TCR
stimulation. LAT /  mice exhibit a profound defect in T
cell development that is similar to that observed in SLP-
76 /  mice, and LAT /  Cbl /  mice show rescued devel-
opment and an overall phenotype similar to that seen in
SLP-76 /  Cbl /  mice. Together, these results suggest
that c-Cbl may normally inhibit a LAT–SLP-76–indepen-
dent pathway that is capable of mediating differentiation of
a CD4  population that can undergo extensive peripheral
expansion and functional polarization. It is notable that this
pathway might be incapable of differentiating a population
of CD25  CD4  regulatory cells, the absence of which
could contribute to extensive CD4  T cell expansion in
vivo. The dramatically decreased expression of both Lck
and ZAP-70 protein in SLP-76 /  Cbl /  CD4 T cells fur-
ther suggests that inactivation of c-Cbl reverses the T cell
defects of SLP-76 /  mice through a pathway that is inde-
pendent of Lck and ZAP-70, as well as SLP-76 and LAT.
The phenotype of peripheral CD4  T cell expansion, as
well as increased constitutive ERK phosphorylation, was
found in LAT /  Cbl /  and SLP-76 /  Cbl /  mice, but
not in c-Cbl /  single knockout mice. A number of mech-Chiang et al. 33
anisms may underlie this observation. First, a molecule re-
sponsible for the unique phenotype of LAT /  Cbl /  and
SLP-76 /  Cbl /  mice may normally be ubiquinated and
degraded via c-Cbl, and might be more stable in the ab-
sence of c-Cbl. The consequences of this stabilization
might be regulated in the presence of a functional TCR
pathway, but not if SLP-76 or LAT is missing. Alterna-
tively, the presence of a normal SLP-76 and LAT-depen-
dent T cell developmental pathway may competitively
suppress the abnormal developmental pathway seen in
SLP-76– or LAT-deficient mice. It is also possible that reg-
ulatory cells such as the CD25  CD4  T regulatory cell
population are dependent upon an intact TCR–SLP-76–
LAT pathway, and function to prevent the abnormal pe-
ripheral expansion of CD4  cells in c-Cbl /  mice.
It is of interest that LAT knock-in mice, expressing a
mutant LAT that has lost the ability to bind PLC- 1, were
recently reported to exhibit defects in T cell development
and to develop splenomegaly (28, 29). The TCR-induced
activation of PLC- 1 and calcium influx is dramatically re-
duced in LAT knock-in CD4  cells, but ERK activation
remains intact. The T cell phenotype of SLP-76 /  Cbl / 
mice is thus similar to that described for mice expressing a
mutated form of LAT. In another LAT knock-in mouse
model, expression of a different mutation in intracellular
tyrosines was recently reported to block    T cell develop-
ment and to partially impair    T cell development (30).
These mice also accumulated large numbers of peripheral T
cells, in this case    T cells, with a Th2 cell phenotype. It
will be of interest to further compare the functional status
of LAT knock-in with LAT /  Cbl /  or SLP-76 / 
Cbl /  mice. Collectively, the patterns of T cell develop-
ment and peripheral dysregulation observed in these genet-
ically altered mice indicate the presence of previously
unrecognized alternative pathways for critical TCR-
dependent signaling in vivo.
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